Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-01
1991-08-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514215, 514248, 514249, 514258, 514300, 514301, 514302, 514303, 546 81, 546113, 546114, 546115, 546118, 546122, 544234, 544236, 544249, 544350, 540578, A61K 3147, C07D47102
Patent
active
050378341
ABSTRACT:
1-Substituted-6-fluoro-7-heterocyclic-1,4-dihydroquino-1-(or dihydronaphthyridin)-4-one carboxylic acids have antibacterial properties. The 7-heterocyclic group is a bicyclic group, one of the rings of which is saturated and the other ring of which is unsaturated.
REFERENCES:
patent: 4146719 (1979-03-01), Irikura
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4530930 (1985-07-01), Uno et al.
patent: 4571396 (1986-02-01), Hutt et al.
patent: 4636506 (1987-01-01), Gilligan et al.
patent: 4665079 (1987-05-01), Culberteon
Brighty Katherine E.
Lowe, III John A.
McGuirk Paul R.
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Shah Mukund J.
Ulnkat Jyothsna
LandOfFree
Heterocycylic-substituted quinoline-carboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycylic-substituted quinoline-carboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycylic-substituted quinoline-carboxylic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987283